ECSP067074A - Derivados de 4-fenil-pirimidina-2-carbonitrilo - Google Patents
Derivados de 4-fenil-pirimidina-2-carbonitriloInfo
- Publication number
- ECSP067074A ECSP067074A EC2006007074A ECSP067074A ECSP067074A EC SP067074 A ECSP067074 A EC SP067074A EC 2006007074 A EC2006007074 A EC 2006007074A EC SP067074 A ECSP067074 A EC SP067074A EC SP067074 A ECSP067074 A EC SP067074A
- Authority
- EC
- Ecuador
- Prior art keywords
- derivatives
- pyrimidine
- phenyl
- carbonitrile
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La invención se refiere a derivados de 4-fenil-pirimidina-2-carbonitrilo que tienen la fórmula general (I) o a una sal farmacéuticamente aceptable de los mismos. La invención también se refiere a composiciones farmacéuticas que comprenden dichos derivados, así como a su uso en la preparación de un medicamento adecuado para el tratamiento de la osteoporosis, aterosclerosis, inflamación y enfermedades inmunológicas tales como artritis reumatoide y dolores crónicos tales como dolores neuropáticos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04253491 | 2004-06-11 | ||
EP04106949 | 2004-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP067074A true ECSP067074A (es) | 2007-01-26 |
Family
ID=34972893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2006007074A ECSP067074A (es) | 2004-06-11 | 2006-12-11 | Derivados de 4-fenil-pirimidina-2-carbonitrilo |
Country Status (27)
Country | Link |
---|---|
US (1) | US7589095B2 (es) |
EP (1) | EP1758870B1 (es) |
JP (1) | JP2008501764A (es) |
KR (1) | KR20070043779A (es) |
CN (1) | CN1980897A (es) |
AR (1) | AR053303A1 (es) |
AT (1) | ATE404542T1 (es) |
AU (1) | AU2005251923A1 (es) |
BR (1) | BRPI0511951A (es) |
CA (1) | CA2567845A1 (es) |
DE (1) | DE602005008960D1 (es) |
DK (1) | DK1758870T3 (es) |
EC (1) | ECSP067074A (es) |
ES (1) | ES2313380T3 (es) |
HK (1) | HK1100002A1 (es) |
IL (1) | IL179444A0 (es) |
MX (1) | MXPA06014423A (es) |
MY (1) | MY140123A (es) |
NO (1) | NO20070146L (es) |
NZ (1) | NZ551772A (es) |
PE (1) | PE20060432A1 (es) |
PL (1) | PL1758870T3 (es) |
PT (1) | PT1758870E (es) |
RS (1) | RS20060662A (es) |
RU (1) | RU2382773C2 (es) |
TW (1) | TW200614993A (es) |
WO (1) | WO2005121106A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008542219A (ja) * | 2005-05-25 | 2008-11-27 | インゲニウム ファーマシューティカルズ ジーエムビーエイチ | 疼痛処置法 |
EP2026654A4 (en) * | 2006-05-26 | 2013-07-17 | Univ Louisville Res Found | MACROPHAGE MIGRATION HEMMFAKTOR ANTAGONISTS AND USE METHOD THEREFOR |
JP5566880B2 (ja) | 2007-04-24 | 2014-08-06 | インゲニウム ファーマシューティカルズ ジーエムビーエイチ | プロテインキナーゼの阻害剤としての4,6−二置換アミノピリミジン誘導体 |
KR100936278B1 (ko) * | 2007-12-14 | 2010-01-13 | 한국생명공학연구원 | 단백질 포스파타제의 활성을 억제하는 피리미딘 유도체또는 이의 약학적으로 허용가능한 염을 유효성분으로함유하는 암 예방 및 치료용 조성물 |
RU2572616C2 (ru) * | 2008-02-01 | 2016-01-20 | Оркид Рисерч Лабораториз Лимитед | Новые гетероциклы |
US9162987B2 (en) | 2009-09-24 | 2015-10-20 | University Of Louisville Research Foundation, Inc. | Iodo pyrimidine derivatives useful for the treatment of macrophage migration inhibitory factor (MIF)-implicated diseases and conditions |
US9155790B2 (en) | 2010-05-20 | 2015-10-13 | University of Lousiville Research Foundation, Inc. | Methods and compositions for modulating ocular damage |
UA114410C2 (uk) | 2011-10-06 | 2017-06-12 | Байєр Інтеллектуал Проперті Гмбх | Гетероциклілпіри(mi)динілпіразол |
US9328118B2 (en) * | 2012-04-17 | 2016-05-03 | Astellas Pharma Inc. | Nitrogen-containing bicyclic aromatic heterocyclic compound |
CN104211645B (zh) * | 2014-08-12 | 2016-08-24 | 武汉珈瑜科技有限公司 | 嘧啶类衍生物及其应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO890521L (no) | 1988-02-25 | 1989-08-28 | Bayer Ag | Substituerte pyrimidiner. |
DE60236851D1 (en) | 2001-02-14 | 2010-08-12 | Warner Lambert Co | Pyrimidinmatrixmetalloproteinaseinhibitoren |
GB0121033D0 (en) | 2001-08-30 | 2001-10-24 | Novartis Ag | Organic compounds |
US20030144234A1 (en) | 2001-08-30 | 2003-07-31 | Buxton Francis Paul | Methods for the treatment of chronic pain and compositions therefor |
AR036375A1 (es) | 2001-08-30 | 2004-09-01 | Novartis Ag | Compuestos pirrolo [2,3-d] pirimidina -2- carbonitrilo, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos |
SE0201980D0 (sv) | 2002-06-24 | 2002-06-24 | Astrazeneca Ab | Novel compounds |
SE0201976D0 (sv) | 2002-06-24 | 2002-06-24 | Astrazeneca Ab | Novel compounds |
GB0220187D0 (en) * | 2002-08-30 | 2002-10-09 | Novartis Ag | Organic compounds |
US7326715B2 (en) * | 2005-09-23 | 2008-02-05 | N.V. Organon | 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
-
2005
- 2005-05-12 TW TW094115416A patent/TW200614993A/zh unknown
- 2005-05-17 MY MYPI20052213A patent/MY140123A/en unknown
- 2005-06-09 BR BRPI0511951-0A patent/BRPI0511951A/pt not_active IP Right Cessation
- 2005-06-09 RU RU2007101161/04A patent/RU2382773C2/ru not_active IP Right Cessation
- 2005-06-09 PL PL05763140T patent/PL1758870T3/pl unknown
- 2005-06-09 DK DK05763140T patent/DK1758870T3/da active
- 2005-06-09 JP JP2007526313A patent/JP2008501764A/ja active Pending
- 2005-06-09 AU AU2005251923A patent/AU2005251923A1/en not_active Abandoned
- 2005-06-09 ES ES05763140T patent/ES2313380T3/es active Active
- 2005-06-09 PE PE2005000659A patent/PE20060432A1/es not_active Application Discontinuation
- 2005-06-09 MX MXPA06014423A patent/MXPA06014423A/es active IP Right Grant
- 2005-06-09 PT PT05763140T patent/PT1758870E/pt unknown
- 2005-06-09 DE DE602005008960T patent/DE602005008960D1/de not_active Expired - Fee Related
- 2005-06-09 KR KR1020077000640A patent/KR20070043779A/ko not_active Application Discontinuation
- 2005-06-09 US US11/628,623 patent/US7589095B2/en not_active Expired - Fee Related
- 2005-06-09 WO PCT/EP2005/006266 patent/WO2005121106A1/en active IP Right Grant
- 2005-06-09 EP EP05763140A patent/EP1758870B1/en active Active
- 2005-06-09 RS RSP-2006/0662A patent/RS20060662A/sr unknown
- 2005-06-09 NZ NZ551772A patent/NZ551772A/en unknown
- 2005-06-09 CN CNA2005800228549A patent/CN1980897A/zh active Pending
- 2005-06-09 CA CA002567845A patent/CA2567845A1/en not_active Abandoned
- 2005-06-09 AR ARP050102347A patent/AR053303A1/es unknown
- 2005-06-09 AT AT05763140T patent/ATE404542T1/de not_active IP Right Cessation
-
2006
- 2006-11-21 IL IL179444A patent/IL179444A0/en unknown
- 2006-12-11 EC EC2006007074A patent/ECSP067074A/es unknown
-
2007
- 2007-01-09 NO NO20070146A patent/NO20070146L/no not_active Application Discontinuation
- 2007-07-18 HK HK07107733A patent/HK1100002A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2007101161A (ru) | 2008-07-20 |
US20080090813A1 (en) | 2008-04-17 |
TW200614993A (en) | 2006-05-16 |
RS20060662A (en) | 2008-09-29 |
WO2005121106A1 (en) | 2005-12-22 |
MY140123A (en) | 2009-11-30 |
HK1100002A1 (en) | 2007-08-31 |
KR20070043779A (ko) | 2007-04-25 |
MXPA06014423A (es) | 2007-02-19 |
JP2008501764A (ja) | 2008-01-24 |
CA2567845A1 (en) | 2005-12-22 |
CN1980897A (zh) | 2007-06-13 |
EP1758870A1 (en) | 2007-03-07 |
NO20070146L (no) | 2007-02-02 |
BRPI0511951A (pt) | 2008-01-29 |
PL1758870T3 (pl) | 2009-01-30 |
AU2005251923A1 (en) | 2005-12-22 |
PT1758870E (pt) | 2008-10-15 |
EP1758870B1 (en) | 2008-08-13 |
PE20060432A1 (es) | 2006-06-23 |
DK1758870T3 (da) | 2008-10-20 |
RU2382773C2 (ru) | 2010-02-27 |
ATE404542T1 (de) | 2008-08-15 |
IL179444A0 (en) | 2007-05-15 |
ES2313380T3 (es) | 2009-03-01 |
US7589095B2 (en) | 2009-09-15 |
NZ551772A (en) | 2009-05-31 |
AR053303A1 (es) | 2007-05-02 |
DE602005008960D1 (de) | 2008-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP067074A (es) | Derivados de 4-fenil-pirimidina-2-carbonitrilo | |
AR124134A2 (es) | Formulación de uso tópico para un inhibidor de jak | |
CO6410279A2 (es) | Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, forma farmacéutica de la misma, procedimiento para su preparación y usos de la misma para el control glucémico mejorado en un paciente. | |
ECSP088654A (es) | Derivados de 6-fenil-1h-imidazo[4,5-c]piridina-4-carbonitrilo como inhibidores de la catepsina k y s | |
DOP2011000264A (es) | Derivados de aminotetralina, composiciones farmaceuticas que los contienen y sus usos en terapia | |
NI201200184A (es) | Morfolinopirimidinas y su uso en terapia | |
BRPI0709581A8 (pt) | compostos de bicicloeteroarila como moduladores de px27 e seu uso | |
CL2007003423A1 (es) | Compuestos derivados de pirimidinas sustituidas; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de artritis reumatoidea, aterosclerosis, entre otras enfermeda | |
BR112012013431A2 (pt) | composto, composição farmacêutica e seu uso | |
CR11857A (es) | Compuestos pirazolicos 436 | |
UY35624A (es) | Uso de dosis elevadas de pridopidina para tratar la enfermedad de huntington | |
BRPI0520669A2 (pt) | dosagem farmacêutica que reduz o efeito do alimento encontrado para administração de atorvastatina | |
UY29085A1 (es) | Derivados de pirimidina 4-sulfonamido sustituidos, compuestos intermedios para su preparación, procedimientos de preparación, composiciones medicinales conteniéndolos y aplicaci0nes | |
GT200600163A (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de la depresion | |
UY31885A (es) | Derivados de las 1, 3, 5-triazina-2, 4-diaminas-6-sustituidas-n-sustituidas y sales farmacéuticamente aceptables de los mismos, composiciones y aplicaciones. | |
BR112012023660B8 (pt) | usos de uma quantidade terapeuticamente eficaz de um composto, ou de um sal, solvato, hidrato ou pró-fármaco farmaceuticamente aceitável do mesmo para o tratamento de câncer | |
CU20120171A7 (es) | Triazolopiridinas sustituidas | |
UA93709C2 (ru) | 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций | |
EA200870469A1 (ru) | Новые, содержащие нимесулид, фармацевтические композиции с низкой дозой, их получение и применение | |
ECSP109966A (es) | Derivados de 6-fenil-1h-imidazo-[4,5-c] piridina-4-carbonitrilo como inhibidores de catepsina | |
CL2012002069A1 (es) | Compuestos derivados de ácido 3-heteroarilamino-propiónico sustituido;inhibidor de proteasa catepsina a; proceso de preparacion; composicion farmaceutica; y su uso para tratar insuficiencia cardiaca, infarto de miocardio, hipertension, artritis reumatoide, asma insuficiencia renal, fobrosis quistica, bronquitis cronica, trombosis, dolor. | |
CY1109537T1 (el) | Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης | |
BR112015001627A2 (pt) | composição farmacêutica, respectivos usos e método para diminuir a frequência de micção | |
UY33745A (es) | Derivados de difenilamina: usos, procedimiento de síntesis y composiciones farmacéuticas | |
CL2007003515A1 (es) | Compuestos derivados de quinolina; procedimiento de preparacion de dichos compuestos; composicion farmaceutica; combinacion farmaceutica; y uso de los compuestos para preparar un medicamento para tratar una infeccion bacteriana. |